On the other hand, previous findings have indicated GSK-3β as a tumour suppressor in breast cancer because it increases the sensitivity of chemotherapy and inhibits PI3K/Akt and Wnt signalling, thus playing a key role in the cell cycle and survival [81, 82]. Here, PIK3CA is linked to breast carcinoma.